| |||||||||
Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation N1 Donating Investigator Zena Harris, Johns Hopkins Univ School of Medicine Description
Mice that are homozygous null for the Cp gene demonstrate a progressive accumulation of iron in hepatocytes and reticuloendothelial cells. By one year of age, iron content of the liver and spleen reaches three to six-fold that observed in wild-type litter mates. The Cp gene product appears to be necessary for proper iron efflux from these cell types. This strain represents a viable murine model for aceruloplasminemia. At one year of age there is no evidence of anemia, diabetes, or neurological symptoms despite iron accumulation at the corresponding tissue sites.Development
The majority of exon 17 and exon 18 has been replaced with a neomycin cassette resulting in the generation of an unstable mRNA.
| Control | ||
|---|---|---|
| None Available | ||
| Considerations for Choosing Controls | ||
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms
Aceruloplasminemia - Models with phenotypic similarity to human disease where etiologies involve orthologs.1
1 Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Cptm1Hrs/Cptm1Hrs
involves: 129X1/SvJ * Black Swiss
- homeostasis/metabolism phenotype
- abnormal iron homeostasis (MGI Ref ID J:57730)
- ferrokinetic studies showed normal rates of iron absorption, initial tissue iron distribution, and plasma iron turnover
- no differences were detected in cellular iron uptake; however, homozygotes displayed a significant impairment in hepatocyte iron efflux
- homozygotes showed elevated serum ferritin
- abnormal iron level (MGI Ref ID J:57730)
- at 1 year of age, there was no evidence of diabetes, anemia, or neurological deficits despite iron accumulation in these sites
- increased liver iron level (MGI Ref ID J:71807)
- hepatic iron displayed a 3.5-fold increase in aceruloplasminemic mice due to loss of ferroxidase function
- progressive accumulation of parenchymal iron, reaching a 3- to 6-fold increase in the iron content of the liver by 1 year of age
- the liver displayed normal cellular architecture with abundant iron in reticuloendothelial cells
- increased spleen iron level (MGI Ref ID J:57730)
- progressive accumulation of parenchymal iron, reaching a 3- to 6-fold increase in the iron content of the spleen by 1 year of age
- the spleen displayed normal cellular architecture with abundant iron in reticuloendothelial cells
- abnormal liver copper level (MGI Ref ID J:71807)
- aceruloplasminemic mice showed normal copper gastrointestinal absorption, hepatic uptake, and biliary copper excretion
- the copper content of brain, heart, spleen, and kidney was normal, and homozygotes exhibited normal copper-zinc superoxide dismutase activity in these tissues
- notably, hepatic copper content was significantly elevated in aceruloplasminemic mice
- hematopoietic system phenotype
- *normal* hematopoietic system phenotype (MGI Ref ID J:57730)
- the hemoglobin concentration remained normal relative to wild-type
- increased spleen iron level (MGI Ref ID J:57730)
- progressive accumulation of parenchymal iron, reaching a 3- to 6-fold increase in the iron content of the spleen by 1 year of age
- the spleen displayed normal cellular architecture with abundant iron in reticuloendothelial cells
- liver/biliary system phenotype
- abnormal liver copper level (MGI Ref ID J:71807)
- aceruloplasminemic mice showed normal copper gastrointestinal absorption, hepatic uptake, and biliary copper excretion
- the copper content of brain, heart, spleen, and kidney was normal, and homozygotes exhibited normal copper-zinc superoxide dismutase activity in these tissues
- notably, hepatic copper content was significantly elevated in aceruloplasminemic mice
- increased liver iron level (MGI Ref ID J:71807)
- hepatic iron displayed a 3.5-fold increase in aceruloplasminemic mice due to loss of ferroxidase function
- progressive accumulation of parenchymal iron, reaching a 3- to 6-fold increase in the iron content of the liver by 1 year of age
- the liver displayed normal cellular architecture with abundant iron in reticuloendothelial cells
- immune system phenotype
- increased spleen iron level (MGI Ref ID J:57730)
- progressive accumulation of parenchymal iron, reaching a 3- to 6-fold increase in the iron content of the spleen by 1 year of age
- the spleen displayed normal cellular architecture with abundant iron in reticuloendothelial cells
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Cptm1Hrs related
Hematological Research
Anemia, Iron Homeostasis Defects
Metabolism Research
Iron Metabolism
Mouse/Human Gene Homologs
aceruloplasminemia
| Allele Symbol | Cptm1Hrs | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Z Leah Harris | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Cp-; | ||
| Mutation Made By | Zena Harris, Johns Hopkins Univ School of Medicine | ||
| Strain of Origin | 129X1/SvJ | ||
| ES Cell Line Name | RW-4 | ||
| ES Cell Line Strain | 129X1/SvJ | ||
| Gene Symbol and Name | Cp, ceruloplasmin | ||
| Chromosome | 3 | ||
| Gene Common Name(s) | CERP; CP-2; D3Ertd555e; DNA segment, Chr 3, ERATO Doi 555, expressed; RATCERP; | ||
| Molecular Note | A neomycin resistance cassette replaced a genomic fragment containing part of exon 17, intron 17 and part of exon 18, which include sequences encoding the residues essential for the formation of the trinuclear copper cluster of the encoded protein. Western blot analysis on serum derived from homozygous mice demonstrated that no detectable encoded protein was present, and activity assays on serum of homozygous mice confirmed that no functional protein is made from this allele. [MGI Ref ID J:57730] | ||
Genotyping Protocols
Cptm1Hrs, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Cptm1Hrs relatedCherukuri S; Potla R; Sarkar J; Nurko S; Harris ZL; Fox PL. 2005. Unexpected role of ceruloplasmin in intestinal iron absorption. Cell Metab 2(5):309-19. [PubMed: 16271531] [MGI Ref ID J:129671]
Cherukuri S; Tripoulas NA; Nurko S; Fox PL. 2004. Anemia and impaired stress-induced erythropoiesis in aceruloplasminemic mice. Blood Cells Mol Dis 33(3):346-55. [PubMed: 15528156] [MGI Ref ID J:95008]
Dunaief JL. 2006. Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. Invest Ophthalmol Vis Sci 47(11):4660-4. [PubMed: 17065470] [MGI Ref ID J:123093]
Hadziahmetovic M; Dentchev T; Song Y; Haddad N; He X; Hahn P; Pratico D; Wen R; Harris ZL; Lambris JD; Beard J; Dunaief JL. 2008. Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci 49(6):2728-36. [PubMed: 18326691] [MGI Ref ID J:136925]
Hahn P; Dentchev T; Qian Y; Rouault T; Harris ZL; Dunaief JL. 2004. Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina. Mol Vis 10:598-607. [PubMed: 15354085] [MGI Ref ID J:93208]
Hahn P; Qian Y; Dentchev T; Chen L; Beard J; Harris ZL; Dunaief JL. 2004. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A 101(38):13850-5. [PubMed: 15365174] [MGI Ref ID J:92620]
Harris ZL; Durley AP; Man TK; Gitlin JD. 1999. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A 96(19):10812-7. [PubMed: 10485908] [MGI Ref ID J:57730]
Meyer LA; Durley AP; Prohaska JR; Harris ZL. 2001. Copper transport and metabolism are normal in aceruloplasminemic mice. J Biol Chem 276(39):36857-61. [PubMed: 11461924] [MGI Ref ID J:71807]
Colony Maintenance
Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| None Available | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.